期刊文献+

肠出血性大肠埃希菌O157:H7Ⅱ型志贺毒素的纯化及功能鉴定 被引量:4

Purification and functional characterization of enterohemorrhagic Escherichia coli O157:H7 Shiga toxin Ⅱ
原文传递
导出
摘要 目的亲和层析纯化肠出血性大肠埃希菌(EHEC)O157:H7Ⅱ型志贺毒素,并鉴定其生物学功能。方法用抗-Ⅱ型志贺毒素分子A亚单位的抗体S1D8耦联至柱填料Sepharose 4B,制备亲和层析柱。纯化EHEC O157:H7菌体分泌的毒素分子,分别用聚丙烯酰胺凝胶电泳(SDS-PAGE)和Western印迹法鉴定毒素分子纯度和特异度,将纯化毒素倍比稀释,观察其对Vero细胞和小鼠的毒性作用,计算其对细胞半数致死量(CD50)和对小鼠的全数致死量(LD100);观察抗毒素血清对小鼠进行毒素攻击的保护作用。结果通过亲和层析从EHEC O157:H7培养物中成功纯化Ⅱ型志贺毒素。SDS-PAGE显示,其A、B亚单位的相对分子质量分别为32000和7500,纯化的毒素分子可分别与Ⅱ型志贺毒素A、B亚单位特异性的单抗结合;对Vero细胞和小鼠均存在致死作用,其CD50和LD100分别为20ng/L和5ng,小鼠体内抗毒素血清对毒素可有效中和。结论成功纯化Ⅱ型志贺毒素,并证实其在细胞和动物模型中的毒性作用。 Objective To purify Shiga toxin Ⅱ(STX Ⅱ) of enterohaemorrhagic Escherichia coli (EHEC) O157:H7 by affinity chromatography, and characterize its biological function. Methods The immno-affinity chromatography column was prepared by STX 11 A subunit-specific antibody $1D8 coupling to Sepharose 4B matrix. The purity and specificity of STX Ⅱ molecule secreted by EHEC O157:H7 were detected by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot, respectively. The purified toxin was serially diluted and the toxic activities to Vero cell line and mice were observed. The 50% cytotoxic dose (CD50) for Vero cell line and 100% lethal dose (LD100) for mice were calculated. The protection effect of anti-STX Ⅱ polysera to the mice against the purified toxin challenge was also observed. Results STX Ⅱ was successfully purified from culture supernatant of EHEC O157 : H7 using affinity chromatography scheme. The relative molecular weights of STX Ⅱ A and B subunits were 32000 and 7500 confirmed by SDS-PAGE, respectively. The purified toxin could react with monoclonal antibodies against STX Ⅱ A and B subunits, respectively. The toxin was cytotoxic to Vero cell with CD50 of 20 ng/L and lethal to mice with LD100 of 5ng.The toxin could be neutralized by anti-STX Ⅱ polysera in vivo. Conclusion STX Ⅱ is successfully purified and its toxic effects are confirmed in both cell line and mouse model.
出处 《中华传染病杂志》 CAS CSCD 北大核心 2008年第4期217-220,共4页 Chinese Journal of Infectious Diseases
基金 基金项目:江苏省自然科学基金资助项目(BK2006242)
关键词 大肠埃希菌O157:H7 志贺毒素 VERO细胞 疾病模型 动物 电泳 聚丙烯酰胺凝 印迹法 蛋白质 Escherichia coli O157: H7 Shiga toxin Vero cells Disease models, animal Electrophoresis, polyacrylamide gel Blotting, Protein
  • 相关文献

参考文献5

  • 1Tzipori S, Sheoran A, Akiyoshi D, et al. Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome. Clin Microbiol Rev, 2004,17: 926-941.
  • 2MacLeod DL, Gyles CL. Purification and characterization of an Escherichia coli Shiga-like toxin Ⅱ variant. Infect Immun, 1990,58:1232-1239.
  • 3Sheoran AS, Chapman S, Singh P, et al. Stx2-specific human monoclonal antibodies protect mice against lethal infection with Escherichia coli expressing Stx2 variants. Infect Immun, 2003,71: 3125-3130.
  • 4Wen SX, Teel LD, Judge NA, et al. Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge. Vaccine, 2006, 24: 1142-1148.
  • 5Beatty ME, Bopp CA, Wells JG, et al. Enterotoxinproducing Escherichia coli O169:H41, United States. Emerg Infect Dis, 2004,10: 518-521.

同被引文献35

  • 1邹全明.肠出血性大肠杆菌O157感染防治研究进展[J].微生物学杂志,2004,24(5):96-98. 被引量:21
  • 2汪华,景怀琦,李红卫,倪大新,赵广法,顾玲,杨晋川,史智扬,刘光中,胡晓抒,徐建国.江苏省淮北地区肠出血性大肠埃希菌O157:H7感染性腹泻并发急性肾衰的研究[J].中华流行病学杂志,2004,25(11):938-940. 被引量:45
  • 3陈洪章,邹全明.肠出血性大肠杆菌(EHEC) O157∶H7志贺毒素研究进展[J].中国人兽共患病学报,2007,23(1):83-85. 被引量:14
  • 4Paton JC, Paton AW. Pathogenesis and diagnosis of Shiga toxin- producing Escherichia coli infections[ J]. Clin Microbiol Rev, 1998, 11(3) : 450 -479.
  • 5Loirat C. Hemolytic uremic syndrome caused by Shiga-toxin-producing Escherichia coli[J]. La Revue du praticien, 2013, 63( 1 ) : 11 - 16.
  • 6Boerlin P, McEwen SA, Boerlin-Petzold F, et al. Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans [ J]. J Clin Microbiol, 1999, 37 ( 3 ) : 497 - 503.
  • 7Sham HP, Shames SR, Crexen MA, et al. Attaching and effacing bacterial effeetor NleC suppresses epithelial inflammatory responses by inhibiting NF-KB and p38 mitogen-aetivated protein kinase activation[J]. Infect Immun, 2011, 79(9) : 3552 -3562.
  • 8Friedrich AW, Bielaszewska M, Zhang WL, et al. Escherichia coli harboring Shiga toxin 2 gene variants : frequency and association with clinical symptoms[J]. J Infect Dis, 2002, 185(I) : 74 -84.
  • 9Paton JC, Paton AW. Pathogenesis and diagnosis of Shiga toxin- produeing Escherichia coli infeetions[ J]. Clin Microbiol Rev, 1998, 11(3) : 450 -479.
  • 10Pfeiffer ML, DuPont HL, Oehoa TJ. The patient presenting with acute dysentery-a systematie review [ J]. J Infeet, 2012, 64 (4) : 374 - 386.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部